The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000591358
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
25/03/2026
Date registered
Help: Date registered
12/05/2026
Date last updated
Help: Date last updated
12/05/2026
Date data sharing statement initially provided
Help: Data sharing statement date
12/05/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Assessing the effectiveness after a less restrictive, faster rehabilitation program following a minimally invasive (“key-hole”) lumbar discectomy for a herniated disc.
Scientific title
Standard versus accelerated rehabilitation for patients undergoing a minimally invasive (“key-hole”) lumbar discectomy for a herniated disc.
Additional trial identifiers [1] 316827 0
none
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
intervertebral disc herniation 341187 0
Condition category
Condition code
Physical Medicine / Rehabilitation 337272 337272 0 0
Other physical medicine / rehabilitation
Musculoskeletal 337590 337590 0 0
Other muscular and skeletal disorders

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Summary:
This trial will investigate whether a less restrictive, accelerated rehabilitation program leads to faster and improved recovery compared with standard rehabiltiation after endoscopic ("key-hole") lumbar discectomy. Participants will be randomly allocated before surgery to either a standard or accelerated rehabilitation program.

In both groups, patient/participant safety and wound healing will be prioritised throughout the study. Routine post-surgical appointments are scheduled with a Nurse Practitioner.

Additionally, both groups will have their rehabilitation programs guided by healthcare professionals at Neurospine Institute, namely by Exercise Physiologists/Biokineticists (company: FitSpines). Standard post-operative rehabilitation provided by FitSpines is delivered one-on-one and tailored to each patient’s needs, abilities, and recovery progress. Care is provided by qualified Exercise Physiologists/Biokineticists and is based on the McGill method from BackFit Pro, which is based on treating the cause of the pain as opposed to just the symptoms of pain. Accordingly, the program is therefore individualised to each patient. Patients typically attend one pre-operative session for education and basic muscle-strengthening exercises, followed by a post-operative session at around 2-4 weeks to review mobility, reinforce safe movement strategies, and progress exercises as appropriate; further sessions may be offered if clinically indicated. The McGill program for spine rehabilitation generally begins with a walking program and light resistance exercises, before progressing to core and resistance work, with progression typically reviewed every two weeks to support a safe and positive recovery. Patients are usually expected to complete their prescribed exercises 3-4 times per week. Exercises may include (but are not limited to) bird dogs, planks, side planks, abdominal curl-ups, glute bridges, and clams. Thera-Band resistance exercises may also be recommended (e.g., pulling, pushing, and shoulder extension movements such as flies). Spinal hygiene education is also provided using practical movement strategies designed to reduce post-operative spinal sensitivity and minimise early rehabilitation risk (e.g. adjacent segment disease and re-herniations associated with repeated flexion). This may include (but are not limited to) instructions on coughing and sneezing, sitting with lumbar support, safe squatting to reach items from the floor, tying shoelaces, and to get in and out of bed or a car. Exercise intensity is adjusted across different levels and prescribed on a case-by-case basis according to the patient’s stage of recovery.

Participants will be followed up by members of the Neurospine Institute research team on a fortnightly basis (until 12 weeks after surgery, then again at 1 and 2 years after surgery), providing regular opportunities to check progress and address any concerns.
Intervention code [1] 333548 0
Rehabilitation
Intervention code [2] 333777 0
Treatment: Other
Description of the comparator or control
Standard post-operative rehabilitation provided by FitSpines is delivered one-on-one and tailored to each patient’s needs, abilities, and recovery progress. Care is provided by qualified Exercise Physiologists/Biokineticists and is based on the McGill method from BackFit Pro. Patients typically attend one pre-operative session for education and basic muscle-strengthening exercises, followed by a post-operative session at around 2–4 weeks to review mobility, reinforce safe movement strategies, and progress exercises as appropriate; further sessions may be offered if clinically indicated. The program generally begins with a walking program and light resistance exercises, before progressing to core and resistance work, with progression typically reviewed every two weeks to support a safe and positive recovery. Patients are usually expected to complete their prescribed exercises 3–4 times per week. Exercises may include (but are not limited to) bird dogs, planks, side planks, abdominal curl-ups, glute bridges, and clams. Thera-Band resistance exercises may also be recommended (e.g., pulling, pushing, and shoulder extension movements such as flies). Exercise intensity is adjusted across different levels and prescribed on a case-by-case basis according to the patient’s stage of recovery.
Control group
Active

Outcomes
Primary outcome [1] 344825 0
Patients achieving a minimal clinically important differences (MCID) in Oswestry Disability Index (ODI).
Timepoint [1] 344825 0
12 weeks post-surgery.
Primary outcome [2] 345081 0
Return to work.
Timepoint [2] 345081 0
questionnaire is asked at 2, 4, 6, 8, 10 and 12 weeks post-surgery.
Secondary outcome [1] 460374 0
Patients achieving a minimal clinically important differences (MCID) in Oswestry Disability Index (ODI).
Timepoint [1] 460374 0
12 weeks post-surgery.
Secondary outcome [2] 460375 0
Return to work.
Timepoint [2] 460375 0
questionnaire is asked at 2, 4, 6, 8, 10 and 12 weeks post-surgery.
Secondary outcome [3] 460376 0
Quality of life measurement.
Timepoint [3] 460376 0
pre-surgery, 2, 4, 6, 8, 10, 12 weeks post-surgery
Secondary outcome [4] 460377 0
Pain rating for back and leg pain.
Timepoint [4] 460377 0
pre-surgery, 2, 4, 6, 8, 10, 12 weeks post-surgery
Secondary outcome [5] 460378 0
Fear-driven avoidance beliefs.
Timepoint [5] 460378 0
pre-surgery, 2, 4, 6, 8, 10, 12 weeks post-surgery
Secondary outcome [6] 460379 0
Fear of movement and (re)injury (kinesiophobia).
Timepoint [6] 460379 0
pre-surgery, 2, 4, 6, 8, 10, 12 weeks post-surgery
Secondary outcome [7] 460380 0
Confidence in doing daily activities despite pain.
Timepoint [7] 460380 0
pre-surgery, 2, 4, 6, 8, 10, 12 weeks post-surgery
Secondary outcome [8] 460381 0
Patient satisfaction.
Timepoint [8] 460381 0
6 and 12 weeks post-surgery
Secondary outcome [9] 460382 0
Walking endurance and functional exercise capacity.
Timepoint [9] 460382 0
pre-surgery, 2, 4 and 12 weeks post-surgery
Secondary outcome [10] 460383 0
Timed functional mobility (sit-to-stand, walking, turning, re-sitting)
Timepoint [10] 460383 0
pre-surgery, 2, 4, and 12 weeks post-surgery

Eligibility
Key inclusion criteria
Patients will only be invited to this study if they meet all of the following:
-- are a patient of Neurospine Institute;
-- if they are at least 18 years old at the time of surgery;
-- if they are scheduled for microdiscectomy or endoscopic discectomy by a Neurospine Institute surgeon;
-- if they provide explicit, prospective informed consent to participate in this study;
-- if they are willing to be randomised prior to surgery;
-- if they intend to complete all standard of care (SoC) pre- and post-surgical care appointments with healthcare professionals, including:

> at Neurospine Institute:
- with FitSpines (at 1-2 weeks pre-surgery, and 4 weeks post-surgery);
- with Nurse Practitioner (at 2 weeks post-surgery);
- with treating surgeon (at 12 weks post-surgery);

-- if they intend to complete patient reported outcome measures (PROMs) and questionnaires, including:

> at baseline (pre-surgery), 2, 4, 6, 8, 10, and 12 weeks post-surgery, and 1 and 2 years post-surgery:
- EQ-5D-5L;
- VAS;
- ODI;
- TSK-17;
- FABQ;
- PSEQ;
- Return to Work Questionnaire;

> at baseline, and 2, 4, and 12 weeks post-surgery:
- 6-minute walk test;
- Timed Up and Go;

> at 6 and 12 weeks post-surgery:
- Patient Satisfaction Questionnaire

-- if patients complete radiological imaging at >1 year post-surgery to confi rm successful fusion (thisimaging is performed as part of standard of care and not specifi cally for this trial).
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
Patients will be excluded from recruitment or during the study if they do not meet all of the inclusion criteria and/any of the below:

- patients who have had previous endoscopic discectomy at Neurospine Institute (as it may not be possible to completely blind patients to either the 'standard' or 'accelerated' group, as similar rehabiliation programs were likely followed for their prior procedure);
- patients who do not have adequate English language proficiency and who do not have access to a translator to provide informed consent;
- patients with psychological complications inhibiting their participation and patients with cognitive impairment who are unable to provide informed consent.

Please note: patients will not be excluded from being invited to the study if they access additional healthcare services outside of NSI (i.e. in addition to the sessions with FitSpines). After participants have been randomised to either ‘standard’ or ‘accelerated’ rehabilitation groups, they will receive written exercises and instructions that they can share with any external healthcare provider. This will help ensure any additional care aligns with the trial rehabilitation program and does not conflict with it.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Participants will be randomised via simple manual allocation using printed allocation slips and an opaque container.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Simple manual allocation from a total pool of printed allocation slips.
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s


Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
WA

Funding & Sponsors
Funding source category [1] 321420 0
Charities/Societies/Foundations
Name [1] 321420 0
Neurospine Foundation
Country [1] 321420 0
Australia
Primary sponsor type
Charities/Societies/Foundations
Name
Neurospine Foundation
Address
Country
Australia
Secondary sponsor category [1] 324165 0
None
Name [1] 324165 0
Address [1] 324165 0
Country [1] 324165 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 319961 0
Curtin University Human Research Ethics Committee
Ethics committee address [1] 319961 0
Ethics committee country [1] 319961 0
Australia
Date submitted for ethics approval [1] 319961 0
26/03/2026
Approval date [1] 319961 0
10/04/2026
Ethics approval number [1] 319961 0
HRE2026-0148

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 148966 0
Prof Gregory Cunningham
Address 148966 0
Neurospine Institute, Suite 77, Wexford Medical Centre, 3 Barry Marshall Parade, Murdoch WA 6150
Country 148966 0
Australia
Phone 148966 0
+61 8 6285 8522
Fax 148966 0
Email 148966 0
Contact person for public queries
Name 148967 0
Dr Jessica Gaff
Address 148967 0
Neurospine Institute, Suite 77, Wexford Medical Centre, 3 Barry Marshall Parade, Murdoch WA 6150
Country 148967 0
Australia
Phone 148967 0
+61 8 6285 8523
Fax 148967 0
Email 148967 0
Contact person for scientific queries
Name 148968 0
Dr Jessica Gaff
Address 148968 0
Neurospine Institute, Suite 77, Wexford Medical Centre, 3 Barry Marshall Parade, Murdoch WA 6150
Country 148968 0
Australia
Phone 148968 0
+61 8 6285 8523
Fax 148968 0
Email 148968 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.